Regulations.gov document
Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public…
Notice · FDA-2016-N-0001 · posted May 31, 2016
Key facts
| Document ID | FDA-2016-N-0001-0063 |
|---|---|
| Title | Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public Workshop; Correction |
| Document type | Notice |
| Subtype | Correction |
| Agency | FDA |
| Docket | FDA-2016-N-0001 |
| Posted | May 31, 2016 |
| Federal Register citation | 81 FR 34348 |
| FR document number | 2016-12654 |
| Comment period opens | May 31, 2016 |
| Effective date | May 31, 2016 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: